Impact of AJCC prognostic staging on prognosis and postmastectomy radiotherapy decision-making in hormone receptor-positive and HER2-positive breast cancer.

Guan-Qiao LiYang YuWen-Wen ZhangPing ZhouChen-Lu LianZhen-Yu HeSan-Gang Wu

Published in: BJS open (2022)

PPS does not provide better risk discriminatory ability in predicting prognosis than AS in patients with node-positive HoR+/HER2+ BC after mastectomy. However, PPS is valuable in providing prognostic counselling to patients and may also guide PMRT decision-making.

Keyphrases

positive breast cancer
end stage renal disease
decision making
lymph node
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
peritoneal dialysis
radiation therapy
breast reconstruction
pet ct
locally advanced
patient reported outcomes
human immunodeficiency virus
hiv testing